Safety and efficacy of IL-17 inhibitors in hidradenitis suppurativa: an updated systematic review and meta-analysis including the BE-HEARD trials

Arch Dermatol Res. 2024 Nov 13;317(1):12. doi: 10.1007/s00403-024-03509-9.

Authors

Mohammad Haris Ali¹, Zayed Mohiyuddin², Muiz Khan Tareen², Muhammad Faizan Safdar², Muhammad Talha³

Affiliations

¹ Department of Medicine, Shaikh Khalifa Bin Zayed Al-Nahyan Medical College, P.O. Box 54600, Lahore, Pakistan. aliharis47@gmail.com.
² Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
³ Department of Medicine, Shaikh Khalifa Bin Zayed Al-Nahyan Medical College, P.O. Box 54600, Lahore, Pakistan.

PMID: 39537996
DOI: 10.1007/s00403-024-03509-9

No abstract available

Keywords: Bimekizumab; CJM112; Hidradenitis suppurativa; IL-17 inhibitors; Secukinumab.

Publication types

Review